TGTX - Company ID 0001001316
TG THERAPEUTICS, INC. (TGTX) reported net income of $447.20M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | $447.20M | +1811.1% |
| FY 2024 | $23.40M | +84.3% |
| FY 2023 | $12.70M | +106.4% |
| FY 2022 | -$198.30M | +43.0% |
| FY 2021 | -$348.10M | -1599.9% |
| FY 2013 | -$20.48M | -13.3% |
| FY 2012 | -$18.07M | -2018.5% |
| FY 2011 | -$853.07K | -236.8% |
| FY 2010 |
TG THERAPEUTICS, INC. (TGTX) reported net income of $447.20M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2004 and fiscal 2025, TG THERAPEUTICS, INC.'s net income grew from -$5.90M to $447.20M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $623.64K |
| +122.3% |
| FY 2009 | -$2.79M | +34.6% |
| FY 2008 | -$4.27M | +64.5% |
| FY 2007 | -$12.03M | -24.1% |
| FY 2006 | -$9.70M | +49.3% |
| FY 2005 | -$19.14M | -224.6% |
| FY 2004 | -$5.90M | - |